Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Allosteric PDK4 Inhibitors: A New Avenue for Metabolic Disea
2026-06-03
This study introduces a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c displaying potent activity and promising in vivo efficacy against metabolic and allergic disease models. The findings highlight a significant advance in targeting metabolic dysregulation for therapeutic intervention.
-
Lypressin Acetate: Applied Protocols for Vasoconstriction &
2026-06-03
Lypressin acetate (Lysine vasopressin acetate) enables reproducible vasoconstriction, antidiuretic assays, and emerging antiviral workflows. This guide translates recent peer-reviewed insights into stepwise protocols, troubleshooting, and advanced applications, maximizing confidence for researchers using APExBIO’s validated peptide.
-
Hexadimethrine Bromide (Polybrene) for Viral Gene Transfecti
2026-06-02
Hexadimethrine Bromide (Polybrene) addresses the challenge of low transduction efficiency in retrovirus- and lentivirus-mediated gene delivery by facilitating viral entry through charge neutralization. It is intended for research applications involving gene transfection workflows, but should not be used for diagnostic or medical purposes. Researchers should adhere to recommended storage and handling practices to maintain product integrity.
-
α-Linolenic Acid in Immune Modulation: Mechanisms and Resear
2026-06-02
Explore how α-Linolenic Acid (ALA) advances immune modulation research through distinct metabolic and signaling pathways. This article provides a deeper mechanistic perspective and practical assay guidance for leveraging ALA’s unique properties in scientific studies.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-06-01
Wang et al. reveal that the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). This mechanistic insight identifies novel regulatory layers of cell death and iron metabolism in cancer, suggesting new targets for sensitizing HCC cells to ferroptosis-based therapies.
-
miR-146a/b-5p–IRAK1–NF-κB Axis in Recurrent Spontaneous Abor
2026-06-01
This study identifies the miR-146a/b-5p–IRAK1–NF-κB signaling axis as a key regulatory mechanism in unexplained recurrent spontaneous abortion (URSA). Using integrative transcriptomic analyses and functional assays, the authors demonstrate that miR-146a/b-5p modulates trophoblast function and inflammation by targeting IRAK1, suggesting potential therapeutic avenues.
-
Cell lysis buffer for WB and IP: Optimizing Tumor Microenvir
2026-05-31
Unlock precise and reproducible protein extraction for Western blot and immunoprecipitation with APExBIO's Cell lysis buffer for WB and IP. This non-denaturing buffer preserves native protein complexes and signaling, empowering advanced tumor microenvironment research and mechanistic studies on chemoresistance.
-
Lypressin Acetate: Benchmarks in Vasopressin Analog Research
2026-05-30
Lypressin acetate is a natural peptide analog of vasopressin, widely used as an antidiuretic and vasopressor agent. Its well-characterized biological activities and stability profile make it a benchmark tool in diabetes insipidus treatment and vasoconstriction research. This article reviews evidence, protocols, and clarifies misconceptions relevant to biomedical research and translational workflows.
-
Allosteric PDK4 Inhibitors for Metabolic and Allergic Diseas
2026-05-29
Jeon et al. present a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, notably compound 8c, which demonstrates nanomolar potency and in vivo efficacy in metabolic and allergic disease models. These findings highlight PDK4’s central role in metabolic regulation and inflammation, offering promising avenues for therapeutic modulation supported by robust chemical and pharmacological profiling.
-
3X (DYKDDDDK) Peptide: Optimizing Flag Tag Protein Workflows
2026-05-29
The 3X (DYKDDDDK) Peptide elevates recombinant protein detection, affinity purification, and structural studies with its hydrophilic, triple-epitope design. Explore protocol enhancements, troubleshooting tips, and the unique advantages of this APExBIO reagent in cutting-edge molecular biology workflows.
-
Stattic: Potent STAT3 Inhibitor for HNSCC & Cancer Biology
2026-05-28
Stattic is a selective STAT3 inhibitor that disrupts STAT3 dimerization and nuclear translocation, leading to reduced tumor growth and enhanced radiosensitivity in head and neck squamous cell carcinoma (HNSCC) models. Its efficacy and specificity make it a key tool for apoptosis induction studies in cancer biology.
-
ApoE-Mimetic Peptide COG133 Modulates miR-146a in Diabetic W
2026-05-28
The referenced study investigates the therapeutic potential of the ApoE-mimetic peptide COG133 in diabetic dermal fibroblasts, focusing on the regulation of miR-146a and its impact on inflammation and antibacterial activity. This work highlights a novel approach to addressing impaired wound healing in diabetes by targeting miRNA-mediated inflammatory pathways.
-
Naloxone Hydrochloride: Beyond Antagonism in Stem Cell and I
2026-05-27
Explore how Naloxone hydrochloride, a leading opioid receptor antagonist, advances neural stem cell research and immune modulation. This article uncovers unique receptor-dependent and independent mechanisms, offering new perspectives for innovative assay design.
-
Substance P: Applied Workflows for Pain and Inflammation Res
2026-05-27
Substance P, a benchmark tachykinin neuropeptide, enables advanced modeling of pain transmission, neuroinflammation, and immune response modulation. This guide delivers actionable workflow enhancements, spectral analytics integration, and troubleshooting strategies to maximize research outcomes using APExBIO’s high-purity Substance P.
-
Sulfo-NHS-SS-Biotin: Advanced Protein Labeling for Affinity
2026-05-26
Sulfo-NHS-SS-Biotin is redefining reversible protein labeling and affinity purification, offering water solubility and a cleavable disulfide bond for precision workflows. Explore how this biotin disulfide N-hydroxysulfosuccinimide ester empowers dynamic proteostasis research and surface-exposed protein analysis with unprecedented flexibility.